Pallas Health vs Strut Health: Clinician-picked pens vs oral plans
Quick verdict: Pallas Health vs Strut Health
Pallas Health is best if you want a clinician to choose between FDA-approved injectable GLP-1 pens and compounded injections with an all-in plan price; Strut Health is best if you specifically want oral semaglutide options with guided consults. This is the short answer for Pallas Health vs Strut Health based on the supplied facts.
See Pallas Health plans and pricing
How these services differ at a glance
This comparison focuses on the most distinctive differences supported by the sources: medication formats offered, pricing and billing structure, clinical model and intake, treatment specialization and availability, and regulatory notes about compounded medications. The rest of the article directly compares Pallas Health vs Strut Health across those areas with the evidence provided.
Medication formats offered
Pallas Health: Offers both FDA-approved brand-name GLP-1 injectables – Wegovy, Ozempic, Zepbound and Mounjaro – and clinician-personalized compounded semaglutide or tirzepatide prepared in the USA when a brand medication is not the right fit. Strut Health: Emphasizes oral-based GLP-1 options and specializes in oral semaglutide lozenges, with guided consultations and oral-focused treatment options.
Explore Strut Health oral options
Pricing and billing structure
Pallas Health publishes a compounded semaglutide price of $139 for the first month, then $597 every 12 weeks which the source frames as a $199/month average. Compounded tirzepatide is $179 first month then $897 every 12 weeks ($299/month average). Pallas also lists cash-pay prices for brand-name medications and states it does not bill insurance. Strut Health is described as having oral GLP-1 from $199 per month in one part of the source, while captured landing evidence also states $99 and free shipping for oral semaglutide; the sources present both price points. Both providers say no insurance billing is needed for their models in the captured material.
Compare Pallas pricing details
Clinical model and intake
Pallas: A US-licensed clinician reviews health history and personalizes the plan; Pallas emphasizes one intake that can cover both brand-name and compounded routes and says eligibility is determined by a US-licensed clinician. Pallas includes clinician review, ongoing check-ins and care-team messaging inside the plan price with no membership fee, and notes asynchronous care in most states with a video visit required in seven states plus Washington, D.C. Strut: Positions guided consults with a clinical team focused on oral medication management, and it notes compounded semaglutide prescriptions require medical necessity reviewed by a licensed physician.
Treatment specialization and user fit
Pallas frames itself as best for patients who want a clinician to choose between brand-name pens and a per-patient compounded preparation. Strut is presented as best for users specifically seeking oral plans, with specialization in oral semaglutide lozenges and associated dosing guidance such as daily sublingual use.
View Strut Health oral plan details
Regulatory and safety notes
Both sources include the regulatory point that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Pallas explicitly states compounded medications are prepared by US-licensed compounding pharmacies and that Pallas does not manufacture or compound medication. Strut likewise notes compounded semaglutide is prepared at a U.S.-licensed compounding pharmacy pursuant to an individualized prescription and that compounded medications are not FDA-approved.
| Criteria | Pallas Health | Strut Health |
|---|---|---|
| Primary medication formats | Brand-name injectables and clinician-personalized compounded injectables | Oral semaglutide specialization, oral lozenges and consults |
| Starting price cited | Compounded semaglutide $139 first month | Source lists from $199 per month; captured landing evidence also shows $99 for oral semaglutide |
| Billing and fees | All-in plan price includes provider care, no membership fee, cash-pay only | No hidden fees claimed, no insurance needed for oral options |
| Clinical intake | US-licensed clinician review; one intake can cover brand or compounded routes | Guided consultations with a focus on oral medication management |
| Compounded medication note | Compounded meds not FDA-approved; prepared by US compounding pharmacies | Compounded meds not FDA-approved; prepared at US-licensed compounding pharmacy |
Pallas Health vs Strut Health – bottom line
For people deciding between Pallas Health vs Strut Health: Pallas gives access to both FDA-approved injectable brand-name GLP-1s and clinician-selected compounded injectables inside an all-in plan price with provider care included. Strut focuses on oral semaglutide and oral-based options with guided consults and an oral-specialist clinical model. Both sources include the regulatory caution that compounded medications are not FDA-approved.
Choose Pallas Health if…
Pallas is the better fit if you want a clinician to choose between an FDA-approved injectable pen and a per-patient compounded injectable, if you prefer an all-in plan price that includes clinician review and messaging, or if you want compounded semaglutide with a $139 first month followed by the published 12-week renewal structure.
Choose Strut Health if…
Strut is the better fit if you specifically seek oral semaglutide or oral GLP-1 lozenges and want a provider that emphasizes guided consults and an oral-focused clinical approach.